Field & Main Bank’s GSK GSK Stock Holding History

Field & Main Bank’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,240	Closed	-$67K	–	282
2022 Q2	$67K	Buy	1,240 +560	+82%	+$30.9K	0.04%	159
2022 Q1	$37K	Hold	680	–	–	0.02%	172
2021 Q4	$37K	Buy	+680	New	+$35.4K	0.02%	177
2021 Q1	–	Sell	-2,212	Closed	-$102K	–	196
2020 Q4	$102K	Sell	2,212 -80	-3%	-$3.67K	0.08%	114
2020 Q3	$108K	Sell	2,292 -80	-3%	-$4.01K	0.08%	112
2020 Q2	$121K	Buy	+2,372	New	+$122K	0.1%	107
2019 Q4	$166K	Sell	2,832 -48	-2%	-$2.67K	0.14%	103
2019 Q3	$154K	Sell	2,880 -400	-12%	-$20.6K	0.14%	104
2019 Q2	$164K	Hold	3,280	–	–	0.15%	107
2019 Q1	$171K	Buy	+3,280	New	+$164K	0.16%	103
2018 Q3	$144K	Sell	2,860 -40	-1%	-$2.03K	0.13%	114
2018 Q2	$151K	Hold	2,900	–	–	0.14%	116
2018 Q1	$142K	Sell	2,900 -80	-3%	-$3.73K	0.14%	117
2017 Q4	$132K	Buy	+2,980	New	+$138K	0.13%	122
2015 Q2	$18K	Hold	340	–	–	0.02%	169
2015 Q1	$20K	Sell	340 -160	-32%	-$9.17K	0.02%	163
2014 Q4	$27K	Buy	500 +160	+47%	+$8.95K	0.03%	146
2014 Q3	$20K	Hold	340	–	–	0.02%	145
2014 Q2	$23K	Hold	340	–	–	0.02%	141
2014 Q1	$23K	Sell	340 -58	-15%	-$3.92K	0.02%	138
2013 Q4	$27K	Buy	+398	New	+$25.8K	0.03%	141

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Field & Main Bank's GSK Position: Q3 2022 in Review

Field & Main Bank sold out of GSK (GSK) in Q3 2022, closing a stake of 1,240 shares — an estimated $67K sold.

Field & Main Bank first reported a position in GSK in Q4 2013 and held it in 21 quarters. The position peaked at $171K in Q1 2019. 742 funds tracked by Wall St. Rank hold GSK as of Q3 2022.

Field & Main Bank reported no remaining GSK position as of Q3 2022 after selling out during the quarter.
Field & Main Bank sold 1,240 GSK shares in Q3 2022, an estimated $67K.
Field & Main Bank first reported a position in GSK in Q4 2013 and held it in 21 quarters.
Field & Main Bank's GSK position peaked at $171K in Q1 2019.
742 funds tracked by Wall St. Rank held GSK as of Q3 2022.

Based on Field & Main Bank's 13F filing for Q3 2022, filed 25 Oct 2022.